There are certainly questions relating to optimization that could be relevant. There's research done in material science as well, and we have had discussions with NRC on the subject.
What else? Pharma is also a field where we expect that we can explore solutions. For now, that will be essentially a toy problem, as we call it, because those systems are not quite scaled yet, as we've mentioned.
Those are the kinds of issues we can start to explore with either NRC or DRDC.